Acute GVHD

9 registered clinical trials studyying Acute GVHD — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Terminated	A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus H NCT05263999	Equillium	Phase 3
Completed	Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT) NCT04645667	UNC Lineberger Comprehensive Cancer Center	—
Recruiting	Prebiotic Galacto-oligosaccharide and Acute GVHD NCT04373057	Duke University	Phase 1 / Phase 2
Terminated	Ruxolitinib and Steroid As First Line Therapy for Acute GVHD NCT03701698	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Phase 2
Completed	A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501) NCT02806947	Medical College of Wisconsin	Phase 2
Active Not Recruiting	Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease NCT02611180	Washington University School of Medicine	—
Completed	Photochemotherapy and Graft-versus-leukemia in Acute-leukemia NCT02631993	Karolinska University Hospital	—
Terminated	Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD) NCT01530256	CSL Behring	Phase 1 / Phase 2
Completed	Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT NCT00350181	Stanford University	Phase 2